Bronchiectasis
253
45
50
110
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
23 trials with published results (9%)
Research Maturity
110 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
18 terminated out of 253 trials
85.9%
-0.6% vs benchmark
17%
44 trials in Phase 3/4
21%
23 of 110 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 110 completed trials
Clinical Trials (253)
Evaluation of Periodontal Treatment in Patients With Bronchiectasis
A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
Natural History of Bronchiectasis
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Cardiovascular Comorbidities and Bronchiectasis
A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared With Placebo in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis
A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)
THERMotherapy Against Persistent Bacterial LUNG Infections
Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease
Breathlessness Perceptions Within Respiratory Diseases
A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases
Itraconazole Therapy In Bronchiectasis With Airway Mold
Azithromycin to Modify Bronchiectasis Exacerbation Risk
BASE: Bronchiectasis Severity and Exacerbation Risk Study
Bronchiectasis Phenotype Identification Model
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
Study of Bronchiectasis and Associated Cardiovascular Comorbidities
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases